Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 5MB, 226 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 15 results:
Author Title Type [ Year(Asc)]
Filters: Author is Dedman, D.  [Clear All Filters]
2021
D. E. Robinson, Ali, M. S., Strauss, V. Y., Elhussein, L., Abrahamsen, B., Arden, N. K., Ben-Shlomo, Y., Caskey, F., Cooper, C., Dedman, D., Delmestri, A., Judge, A., Javaid, M. K., and Prieto-Alhambra, D., “Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study”, Health Technol Assess, vol. 25, pp. 1-106, 2021.
G. Requena, Dedman, D., Quint, J. K., Ghosh, R. E., Williams, R., and Pimenta, J. M., “The Utilization and Safety of Umeclidinium and Umeclidinium/Vilanterol in UK Primary Care: A Retrospective Cohort Study”, Int J Chron Obstruct Pulmon Dis, vol. 16, pp. 629-642, 2021.
2020
E. M. Heintjes, Bezemer, I. D., Prieto-Alhambra, D., Smits, E., Booth, H. P., Dedman, D., He, Y., Hoti, F., Vehkala, M., de Vogel, S., Robinson, N. J., Appenteng, K., and van Beest, F. J. A. Penn, “Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European Countries”, Clin Epidemiol, vol. 12, pp. 423-433, 2020.
G. Requena, Wolf, A., Williams, R., Dedman, D., Quint, J. K., Murray-Thomas, T., and Pimenta, J. M., “Feasibility of using Clinical Practice Research Datalink data to identify patients with chronic obstructive pulmonary disease to enrol into real-world trials”, Pharmacoepidemiol Drug Saf, 2020.
D. A. Enoch, Murray-Thomas, T., Adomakoh, N., Dedman, D., Georgopali, A., Francis, N., and Karas, A., “Risk of complications and mortality following recurrent and non-recurrent Clostridioides difficile infection: a retrospective, observational, database study in England”, J Hosp Infect, 2020.
D. E. Robinson, Ali, M. S., Pallares, N., Tebe, C., Elhussein, L., Abrahamsen, B., Arden, N. K., Ben-Shlomo, Y., Caskey, F. J., Cooper, C., Dedman, D., Delmestri, A., Judge, A., Perez-Saez, M. J., Pascual, J., Nogues, X., Diez-Perez, A., Strauss, V. Y., Javaid, M. K., and Prieto-Alhambra, D., “Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a bi-national cohort analysis”, J Bone Miner Res, 2020.
2019
A. M. Gallagher, Dedman, D., Padmanabhan, S., Leufkens, H. G. M., and de Vries, F., “The accuracy of date of death recording in the Clinical Practice Research Datalink GOLD database in England compared with the Office for National Statistics death registrations”, Pharmacoepidemiol Drug Saf, 2019.
A. Wolf, Dedman, D., Campbell, J., Booth, H., Lunn, D., Chapman, J., and Myles, P., “Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum”, Int J Epidemiol, 2019.
H. Strongman, Williams, R., Meeraus, W., Murray-Thomas, T., Campbell, J., Carty, L., Dedman, D., Gallagher, A., Oyinlola, J., Kousoulis, A., and Valentine, J., “Limitations for health research with restricted data collection from UK primary care”, Pharmacoepidemiol Drug Saf, 2019.
D. Dedman, Coton, S. J., Ghosh, R. E., Meeraus, W., Crim, C., Harvey, C., Amelio, J., and Landis, S. H., “Treatment Patterns of New Users of Fluticasone Furoate/Vilanterol in Asthma and COPD in UK Primary Care: Retrospective Cohort Study”, Pulmonary Therapy, vol. 5, pp. 81-95, 2019.
2018
J. Castellsague, Kuiper, J. G., Pottegard, A., I. Berglind, A., Dedman, D., Gutierrez, L., Calingaert, B., van Herk-Sukel, M. P., Hallas, J., Sundstrom, A., Gallagher, A. M., Kaye, J. A., Pardo, C., Rothman, K. J., and Perez-Gutthann, S., “A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation - JOELLE study)”, Clin Epidemiol, vol. 10, pp. 299-310, 2018.
J. G. Kuiper, van Herk-Sukel, M. P. P., Castellsague, J., Pottegard, A., Berglind, I. A., Dedman, D., Gutierrez, L., Calingaert, B., Hallas, J., Sundstrom, A., Gallagher, A. M., Kaye, J. A., Pardo, C., Rothman, K. J., and Perez-Gutthann, S., “Use of Topical Tacrolimus and Topical Pimecrolimus in Four European Countries: A Multicentre Database Cohort Study”, Drugs Real World Outcomes, 2018.
2016
A. Lane, Metcalfe, C., Young, G. J., Peters, T. J., Blazeby, J., Avery, K. N., Dedman, D., Down, L., Mason, M. D., Neal, D. E., Hamdy, F. C., and Donovan, J. L., “Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life”, BJU Int, vol. 118, pp. 869-879, 2016.
2015
S. de Lusignan, Liaw, S. T., Dedman, D., Khunti, K., Sadek, K., and Jones, S., “An algorithm to improve diagnostic accuracy in diabetes in computerised problem orientated medical records (POMR) compared with an established algorithm developed in episode orientated records (EOMR)”, J Innov Health Inform, vol. 22, pp. 255-64, 2015.
2013
J. A. Lopez Bernal, Upton, M. N., Henderson, A. J., Dedman, D., McCarthy, A., G. Smith, D., and Ben-Shlomo, Y., “Lower respiratory tract infection in the first year of life is associated with worse lung function in adult life: prospective results from the Barry Caerphilly Growth study”, Ann Epidemiol, vol. 23, pp. 422-7, 2013.
[Page last reviewed 6 April 2021]